"at these levels may be akin to buying Regeneron (REGN) at $5 in...

"at these levels may be akin to buying Regeneron (REGN) at $5 in 2005 (currently trading at $296) or Pharmacyclics (PCYC) at $4 in 2011 (currently at $127)."

They may be chickenfeed to what Novogen could possibly get to if what Prof Kelly hinted at recently, he mentioned $50 per share for NRT possibly and within two years perhaps?

I know the GK was perhaps being a bit too upbeat possibly, but $20 I reckon is not out of the question if things fall into place?

I am thinking there may be some sort of deal with a large Pharma shortly? it may already be in train?

Here's hoping anyway, even if it is for one platform only? it would give much credence to Novogen and the drugs they have, let alone a completely new method of manufacturing that not only applies to cancer drugs but many other drugs as well.